Microbot Medical Inc. (NASDAQ:MBOT) Short Interest Update

Microbot Medical Inc. (NASDAQ:MBOT) was the target of a significant increase in short interest during the month of December. As of December 31st, there was short interest totalling 1,040,000 shares, an increase of 80.0% from the December 15th total of 577,700 shares. Based on an average daily trading volume, of 2,030,000 shares, the short-interest ratio is presently 0.5 days.

Microbot Medical Stock Down 7.1 %

NASDAQ MBOT traded down $0.13 during trading on Friday, reaching $1.65. 2,162,501 shares of the stock traded hands, compared to its average volume of 11,620,619. The stock’s 50-day moving average price is $1.19 and its 200 day moving average price is $1.05. The firm has a market cap of $33.46 million, a price-to-earnings ratio of -2.08 and a beta of 1.46. Microbot Medical has a fifty-two week low of $0.82 and a fifty-two week high of $3.38.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Microbot Medical stock. Thoroughbred Financial Services LLC purchased a new position in shares of Microbot Medical Inc. (NASDAQ:MBOT) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 52,250 shares of the biotechnology company’s stock, valued at approximately $53,000. Thoroughbred Financial Services LLC owned about 0.33% of Microbot Medical as of its most recent SEC filing. Institutional investors and hedge funds own 16.30% of the company’s stock.

Microbot Medical Company Profile

Microbot Medical Inc, a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces.